RAC1 and cancer: One option would be to inhibit specific cancer-associated RAC1-GEFS, an approach exemplified by inhibitors such as NSC23766, a small-molecule inhibitor which blocks the interaction of a subset of GEFs, including TIAM1, with RAC1.